Extensive hypertrophic lupus erythematosus: Atypical presentation

Lupus erythematosus (LE) is a disease with a wide spectrum of cutaneous and systemic manifestations. Clinical features of patients with LE show a great variation, and for this reason it is difficult to develop a unifying concept of this disease. Our objective is to present a case of hypertrophic LE...

Full description

Bibliographic Details
Main Authors: Tarun Narang, Meghna Sharma, Nigabh Gulati, Anureet Kaur
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2012-01-01
Series:Indian Journal of Dermatology
Subjects:
Online Access:http://www.e-ijd.org/article.asp?issn=0019-5154;year=2012;volume=57;issue=6;spage=504;epage=504;aulast=Narang
id doaj-2493a6ddb4544b7d852891d9e8dda8d0
record_format Article
spelling doaj-2493a6ddb4544b7d852891d9e8dda8d02020-11-24T22:53:19ZengWolters Kluwer Medknow PublicationsIndian Journal of Dermatology0019-51541998-36112012-01-0157650450410.4103/0019-5154.103085Extensive hypertrophic lupus erythematosus: Atypical presentationTarun NarangMeghna SharmaNigabh GulatiAnureet KaurLupus erythematosus (LE) is a disease with a wide spectrum of cutaneous and systemic manifestations. Clinical features of patients with LE show a great variation, and for this reason it is difficult to develop a unifying concept of this disease. Our objective is to present a case of hypertrophic LE with atypical morphology and extensive involvement, who responded favorably to isotretinoin. Diagnosis of hypertrophic lupus erythematosus (HLE) was confirmed by characteristic histopathological findings. Combination therapy with isotretinoin and hydroxychloroquine resulted in flattening and repression of previously refractory skin lesions. Sometimes, HLE lesions may present a diagnostic and therapeutic dilemma. In long standing lesions, squamous cell carcinoma may arise. Therefore, HLE requires adequate therapy with clinical and histopathological follow up.http://www.e-ijd.org/article.asp?issn=0019-5154;year=2012;volume=57;issue=6;spage=504;epage=504;aulast=NarangAtypicalextensivehypertrophic lupus erythematosusisotretinoin
collection DOAJ
language English
format Article
sources DOAJ
author Tarun Narang
Meghna Sharma
Nigabh Gulati
Anureet Kaur
spellingShingle Tarun Narang
Meghna Sharma
Nigabh Gulati
Anureet Kaur
Extensive hypertrophic lupus erythematosus: Atypical presentation
Indian Journal of Dermatology
Atypical
extensive
hypertrophic lupus erythematosus
isotretinoin
author_facet Tarun Narang
Meghna Sharma
Nigabh Gulati
Anureet Kaur
author_sort Tarun Narang
title Extensive hypertrophic lupus erythematosus: Atypical presentation
title_short Extensive hypertrophic lupus erythematosus: Atypical presentation
title_full Extensive hypertrophic lupus erythematosus: Atypical presentation
title_fullStr Extensive hypertrophic lupus erythematosus: Atypical presentation
title_full_unstemmed Extensive hypertrophic lupus erythematosus: Atypical presentation
title_sort extensive hypertrophic lupus erythematosus: atypical presentation
publisher Wolters Kluwer Medknow Publications
series Indian Journal of Dermatology
issn 0019-5154
1998-3611
publishDate 2012-01-01
description Lupus erythematosus (LE) is a disease with a wide spectrum of cutaneous and systemic manifestations. Clinical features of patients with LE show a great variation, and for this reason it is difficult to develop a unifying concept of this disease. Our objective is to present a case of hypertrophic LE with atypical morphology and extensive involvement, who responded favorably to isotretinoin. Diagnosis of hypertrophic lupus erythematosus (HLE) was confirmed by characteristic histopathological findings. Combination therapy with isotretinoin and hydroxychloroquine resulted in flattening and repression of previously refractory skin lesions. Sometimes, HLE lesions may present a diagnostic and therapeutic dilemma. In long standing lesions, squamous cell carcinoma may arise. Therefore, HLE requires adequate therapy with clinical and histopathological follow up.
topic Atypical
extensive
hypertrophic lupus erythematosus
isotretinoin
url http://www.e-ijd.org/article.asp?issn=0019-5154;year=2012;volume=57;issue=6;spage=504;epage=504;aulast=Narang
work_keys_str_mv AT tarunnarang extensivehypertrophiclupuserythematosusatypicalpresentation
AT meghnasharma extensivehypertrophiclupuserythematosusatypicalpresentation
AT nigabhgulati extensivehypertrophiclupuserythematosusatypicalpresentation
AT anureetkaur extensivehypertrophiclupuserythematosusatypicalpresentation
_version_ 1725663782479331328